Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D Perrier

Showing results (211-220 of 249) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez, Maria E Cabanillas, Libero Santarpia, et al.
Annals of Surgical Oncology|December 9, 2017
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical CarcinomaMinerva Angélica Romero Arenas, Timothy G Whitsett, Anna Aronova, et al.
Journal of the Endocrine Society|February 22, 2019
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core PathwaysCallisia N Clarke, Panagiotis Katsonis, Teng-Kuei Hsu, et al.
Oncology Reports|April 22, 2008
Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancerBeth O Van Emburgh, Jennifer J Hu, Edward A Levine, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
Journal of the American College of Surgeons|January 5, 2024
Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical PathwaysAhad Azimuddin, Ching-Wei D Tzeng, Laura R Prakash, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
Familial Cancer|September 28, 2013
Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromesThereasa A Rich, Mei Liu, Carol J Etzel, et al.
Annals of Surgical Oncology|January 7, 2003
Positron emission mammography: initial clinical resultsEdward A Levine, Rita I Freimanis, Nancy D Perrier, et al.
Pageof 25

Showing results (211-220 of 249) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez, Maria E Cabanillas, Libero Santarpia, et al.
Annals of Surgical Oncology|December 9, 2017
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical CarcinomaMinerva Angélica Romero Arenas, Timothy G Whitsett, Anna Aronova, et al.
Journal of the Endocrine Society|February 22, 2019
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core PathwaysCallisia N Clarke, Panagiotis Katsonis, Teng-Kuei Hsu, et al.
Oncology Reports|April 22, 2008
Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancerBeth O Van Emburgh, Jennifer J Hu, Edward A Levine, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
Journal of the American College of Surgeons|January 5, 2024
Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical PathwaysAhad Azimuddin, Ching-Wei D Tzeng, Laura R Prakash, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
Familial Cancer|September 28, 2013
Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromesThereasa A Rich, Mei Liu, Carol J Etzel, et al.
Annals of Surgical Oncology|January 7, 2003
Positron emission mammography: initial clinical resultsEdward A Levine, Rita I Freimanis, Nancy D Perrier, et al.
Pageof 25